HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mary Cushman Selected Research

C-Reactive Protein

1/2022C-reactive Protein and Racial Differences in Type 2 Diabetes Incidence: The REGARDS Study.
11/2021Cardiovascular damage phenotypes and all-cause and CVD mortality in older adults.
10/2021Temporal change in inflammatory biomarkers and risk of cardiovascular events: the Multi-ethnic Study of Atherosclerosis.
1/2021Hemostatic factors, inflammatory markers, and risk of incident venous thromboembolism: The Multi-Ethnic Study of Atherosclerosis.
1/2021C-Reactive Protein and Incident Hypertension in Black and White Americans in the REasons for Geographic And Racial Differences in Stroke (REGARDS) Cohort Study.
11/2020Thromboinflammation response to tocilizumab in COVID-19.
1/2020C-reactive protein and risk of cognitive decline: The REGARDS study.
1/2020Interferon gamma-induced protein 10 (IP-10) and cardiovascular disease in African Americans.
1/2020Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis.
11/2019C-reactive protein and stroke risk in blacks and whites: The REasons for Geographic And Racial Differences in Stroke cohort.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mary Cushman Research Topics

Disease

89Stroke (Strokes)
11/2022 - 02/2002
85Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 02/2002
83Atherosclerosis
07/2022 - 08/2003
63Inflammation (Inflammations)
11/2022 - 01/2002
49Venous Thromboembolism
12/2021 - 04/2002
44Hypertension (High Blood Pressure)
02/2022 - 04/2002
40Coronary Disease (Coronary Heart Disease)
11/2022 - 08/2003
34Ischemic Stroke
02/2022 - 07/2003
26Venous Thrombosis (Deep-Vein Thrombosis)
07/2021 - 01/2002
24Heart Failure
02/2022 - 05/2003
24Neoplasms (Cancer)
01/2022 - 12/2002
23Obesity
12/2020 - 03/2003
18Thrombosis (Thrombus)
11/2020 - 02/2003
15Chronic Renal Insufficiency
01/2022 - 04/2005
15COVID-19
01/2022 - 01/2020
14Myocardial Infarction
01/2018 - 08/2003
12Thromboembolism
01/2020 - 12/2002
11Cognitive Dysfunction
04/2021 - 09/2012
11Atrial Fibrillation
01/2021 - 02/2002
10Critical Illness (Critically Ill)
01/2022 - 05/2009
10Hemorrhage
10/2021 - 04/2003
9Chronic Kidney Failure (Chronic Renal Failure)
07/2022 - 04/2007
8Kidney Diseases (Kidney Disease)
10/2022 - 05/2008
7Diabetes Mellitus
01/2021 - 05/2007
7Insulin Resistance
01/2021 - 02/2007
7Peripheral Arterial Disease
01/2019 - 02/2016
7Vascular Diseases (Vascular Disease)
01/2014 - 01/2004
6Fibrosis (Cirrhosis)
07/2022 - 10/2018
6Type 2 Diabetes Mellitus (MODY)
01/2022 - 06/2009
6Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2021 - 11/2008
6Activated Protein C Resistance (APC Resistance)
01/2021 - 04/2002
6Thrombophilia
01/2020 - 01/2002
6Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
04/2015 - 02/2002
5Dyslipidemias (Dyslipidemia)
10/2022 - 01/2012
5Heart Diseases (Heart Disease)
01/2019 - 09/2006
4Renal Insufficiency (Renal Failure)
10/2022 - 05/2008
4Thrombocytopenia (Thrombopenia)
03/2021 - 05/2009
4Infections
01/2020 - 11/2007

Drug/Important Bio-Agent (IBA)

70C-Reactive ProteinIBA
01/2022 - 12/2002
63Biomarkers (Surrogate Marker)IBA
11/2022 - 04/2005
41Interleukin-6 (Interleukin 6)IBA
11/2021 - 08/2004
29fibrin fragment D (D-dimer)IBA
12/2021 - 01/2002
25Fibrinogen (Factor I)FDA Link
10/2021 - 12/2002
23Hormones (Hormone)IBA
01/2021 - 10/2004
17AlbuminsIBA
01/2022 - 03/2004
16Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2021 - 07/2008
15Hemostatics (Antihemorrhagics)IBA
10/2022 - 01/2002
15CreatinineIBA
01/2022 - 02/2002
15Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 11/2005
15Factor VIII (Coagulation Factor VIII)IBA
01/2021 - 12/2002
15Brain Natriuretic Peptide (Natrecor)FDA Link
01/2021 - 09/2010
15Estrogens (Estrogen)FDA Link
02/2016 - 08/2003
14LipidsIBA
01/2022 - 04/2002
14pro-brain natriuretic peptide (1-76)IBA
01/2021 - 11/2012
14LDL CholesterolIBA
10/2020 - 09/2005
141-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
01/2018 - 05/2008
12AnticoagulantsIBA
01/2022 - 06/2002
12Cystatin CIBA
11/2021 - 12/2005
12CalciumIBA
10/2021 - 05/2007
12Glucose (Dextrose)FDA LinkGeneric
10/2020 - 01/2002
12LeptinIBA
03/2018 - 02/2007
11Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 05/2009
11CholesterolIBA
10/2021 - 05/2004
11HDL CholesterolIBA
10/2020 - 10/2008
11AdiponectinIBA
01/2019 - 02/2007
10factor V LeidenIBA
02/2022 - 04/2002
10Warfarin (Coumadin)FDA LinkGeneric
03/2021 - 12/2002
10Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021 - 07/2008
10Protein CIBA
01/2021 - 04/2002
10ResistinIBA
01/2019 - 07/2011
9Insulin (Novolin)FDA Link
07/2016 - 01/2002
8Proteins (Proteins, Gene)FDA Link
07/2022 - 04/2002
8Hemoglobins (Hemoglobin)IBA
03/2021 - 10/2005
8AntigensIBA
01/2021 - 04/2002
8HomocysteineIBA
03/2018 - 03/2003
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 04/2005
7Prothrombin (Factor II)IBA
02/2022 - 04/2002
7Natriuretic PeptidesIBA
11/2021 - 02/2014
7Blood Coagulation Factors (Coagulation Factor)IBA
01/2021 - 07/2002
7Antifibrinolytic Agents (Antifibrinolytics)IBA
01/2021 - 06/2009
7Biological ProductsIBA
11/2020 - 07/2009
7CytokinesIBA
11/2020 - 06/2007
7InterleukinsIBA
01/2019 - 02/2010
7AdipokinesIBA
09/2015 - 06/2007
6lipoprotein-associated coagulation inhibitor (TFPI)IBA
01/2021 - 08/2010
6von Willebrand FactorIBA
01/2019 - 12/2002
6Progestins (Progestagens)IBA
02/2016 - 08/2003
6Estradiol (Delestrogen)FDA LinkGeneric
09/2015 - 08/2003
5FibrinolysinFDA Link
01/2021 - 06/2009
5Lipoprotein(a)IBA
11/2020 - 02/2016
5Pharmaceutical PreparationsIBA
11/2020 - 08/2003
5Gonadal Steroid Hormones (Sex Hormones)IBA
05/2016 - 06/2009
4NeurotensinIBA
01/2022 - 01/2020
4neuromedin NIBA
01/2022 - 01/2020
4vinyltriethoxysilane (VTES)IBA
12/2020 - 02/2014
4Vitamin KFDA Link
01/2020 - 04/2002
4AntithrombinsIBA
01/2020 - 06/2002

Therapy/Procedure

37Therapeutics
10/2022 - 04/2003
6Hormone Replacement Therapy (Therapy, Hormone Replacement)
11/2018 - 07/2002
5Secondary Prevention
01/2021 - 05/2013